Simplex Trading’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$271K Buy
149,700
+129,000
+623% +$223K ﹤0.01% 3931
2025
Q4
$27.9K Buy
20,700
+4,800
+30% +$6.83K ﹤0.01% 6173
2025
Q3
$25K Sell
15,900
-1,100
-6% -$1.22K ﹤0.01% 7143
2025
Q2
$16K Buy
17,000
+10,900
+179% +$9.04K ﹤0.01% 6967
2025
Q1
$4K Sell
6,100
-15,400
-72% -$10.7K ﹤0.01% 7705
2024
Q4
$17K Buy
21,500
+100
+0.5% +$92 ﹤0.01% 6818
2024
Q3
$21K Sell
21,400
-1,800
-8% -$2.47K ﹤0.01% 6645
2024
Q2
$35K Sell
23,200
-9,100
-28% -$14.2K ﹤0.01% 6415
2024
Q1
$52K Buy
+32,300
New +$27.1K ﹤0.01% 6224
2023
Q3
Sell
-2,800
Closed -$1K 9483
2023
Q2
$1K Buy
2,800
+1,400
+100% +$898 ﹤0.01% 8679
2023
Q1
$1K Sell
1,400
-7,000
-83% -$7.63K ﹤0.01% 8738
2022
Q4
$10K Sell
8,400
-53,200
-86% -$82.9K ﹤0.01% 7556
2022
Q3
$109K Sell
61,600
-67,800
-52% -$169K ﹤0.01% 5400
2022
Q2
$293K Sell
129,400
-89,900
-41% -$215K ﹤0.01% 4130
2022
Q1
$723K Sell
219,300
-111,900
-34% -$393K ﹤0.01% 3352
2021
Q4
$1.51M Sell
331,200
-154,700
-32% -$1.17M ﹤0.01% 2343
2021
Q3
$3.8M Buy
485,900
+7,000
+1% +$51.4K ﹤0.01% 1449
2021
Q2
$3.85M Buy
478,900
+477,738
+41,113% +$4.03M ﹤0.01% 1427
2021
Q1
$788K Buy
+1,162
New +$7.73K ﹤0.01% 2726

Other funds holding OCGN

Simplex Trading's OCGN Position: Q1 2026 in Review

Simplex Trading sold out of Ocugen (OCGN) in Q1 2026, closing a stake of 72,385 shares — an estimated $125K sold.

Simplex Trading first reported a position in OCGN in Q1 2023 and held it in 12 quarters. The position peaked at $305K in Q1 2024. 137 funds tracked by Wall St. Rank hold OCGN as of Q1 2026.

  • Simplex Trading reported no remaining Ocugen position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 72,385 Ocugen shares in Q1 2026, an estimated $125K.
  • Simplex Trading first reported a position in Ocugen in Q1 2023 and held it in 12 quarters.
  • Simplex Trading's Ocugen position peaked at $305K in Q1 2024.
  • 137 funds tracked by Wall St. Rank held Ocugen as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.